IKNA - Ikena Oncology Inc
IEX Last Trade
1.71
0.020 1.170%
Share volume: 30,386
Last Updated: Fri 30 Aug 2024 09:59:57 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$1.69
0.02
1.18%
View ratios
Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
Report Date | 2022-08-11 | 2022-11-07 | 2023-03-14 | 2023-05-15 | 2023-08-10 | 2023-11-09 | 2024-03-12 | 2024-05-13 | |
Total revenue | 382.000 K | 6.402 M | 5.450 M | 5.313 M | 2.004 M | 1.185 M | 658.000 K | 0.000 | |
Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Gross profit | 382.000 K | 6.402 M | 5.450 M | 5.313 M | 2.004 M | 1.185 M | 658.000 K | 0.000 | |
1,575.92% | -14.87% | -2.51% | -62.28% | -40.87% | -44.47% | -100.00% | |||
Operating expenses | 21.333 M | 24.278 M | 20.565 M | 20.828 M | 20.494 M | 20.688 M | 22.567 M | 15.644 M | |
Selling general and admin | 5.845 M | 5.428 M | 4.925 M | 5.276 M | 5.322 M | 6.034 M | 8.293 M | 5.999 M | |
Research and development | 15.488 M | 18.850 M | 15.640 M | 15.552 M | 15.172 M | 14.654 M | 14.274 M | 9.645 M | |
Total expenses | 21.333 M | 24.278 M | 20.565 M | 20.828 M | 20.494 M | 20.688 M | 22.567 M | 15.644 M | |
13.80% | -15.29% | 1.28% | -1.60% | 0.95% | 9.08% | -30.68% | |||
Operating income | -20.951 M | -17.876 M | -15.115 M | -15.515 M | -18.490 M | -19.503 M | -21.909 M | -15.644 M | |
Ebit | -20.951 M | -17.876 M | -15.115 M | -15.515 M | -18.490 M | -19.503 M | -21.909 M | -15.644 M | |
Pretax income | -20.491 M | -17.338 M | -14.097 M | -14.219 M | -17.115 M | -17.343 M | -19.651 M | -16.119 M | |
-15.39% | -18.69% | 0.87% | 20.37% | 1.33% | 13.31% | -17.97% | |||
Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 27.000 K | |
Net income basic | -20.491 M | -17.338 M | -14.097 M | -14.219 M | -17.115 M | -17.343 M | -19.651 M | -16.146 M | |
15.39% | 18.69% | -0.87% | -20.37% | -1.33% | -13.31% | 17.84% | |||
Net income | -20.491 M | -17.338 M | -14.097 M | -14.219 M | -17.115 M | -17.343 M | -19.651 M | -16.146 M | |
15.39% | 18.69% | -0.87% | -20.37% | -1.33% | -13.31% | 17.84% |